Rodríguez-Blázquez Carmen, Alvarez Mario, Arakaki Tomoko, Campos Arillo Víctor, Chaná Pedro, Fernández William, Garretto Nélida, Martínez-Castrillo Juan Carlos, Rodríguez-Violante Mayela, Serrano-Dueñas Marcos, Ballesteros Diego, Rojo-Abuin Jose Manuel, Ray Chaudhuri Kallol, Merello Marcelo, Martínez-Martín Pablo
National Center of Epidemiology and CIBERNED Carlos III Institute of Health Madrid Spain.
Department of Movement Disorders and Neurodegeneration CIREN La Habana Cuba.
Mov Disord Clin Pract. 2017 Jan 5;4(4):529-535. doi: 10.1002/mdc3.12462. eCollection 2017 Jul-Aug.
Parkinson's disease (PD) is characterized by motor and nonmotor symptoms that progress with time, causing disability. The performance of a disease-specific, self-applied tool for assessing disability, the MDS-UPDRS Part II, is tested against generic and rater-based rating scales.
An international, cross-sectional, observational study was performed. Patients were assessed with the Hoehn and Yahr (HY) and five disability measures: MDS-UPDRS Part II, Schwab and England Scale (S&E), Clinical Impression of Severity Index-PD (CISI-PD) Disability item, Barthel Index (BI), and Rapid Assessment of Disability Scale (RADS). Data analysis included correlation coefficients, Mann-Whitney and Kruskal-Wallis tests, and intraclass-correlation coefficient for concordance.
The sample was composed of 451 patients, 55.2% men, with a mean age of 65.06 years (SD = 10.71). Disability rating scales correlated from |0.75| (CISI-PD Disability with BI) to 0.87 (MDS-UPDRS Part II with RADS). In general, MDS-UPDRS Part II showed high correlation coefficients with clinical variables and satisfactory concordance with the rest of disability measures, with ICC ranging from 0.83 (with BI) to 0.93 (with RADS). All disability rating scales showed statistical significant differences in the sample grouped by sex, age, disease duration, and severity level.
The MDS-UPDRS Part II showed an appropriate performance to assess disability in PD, even better than some rater-based, generic or specific, scales applied in this study.
帕金森病(PD)的特征是运动和非运动症状随时间进展,导致残疾。针对一种用于评估残疾的疾病特异性自我应用工具——MDS-UPDRS第二部分,与通用和基于评估者的评定量表进行了对比测试。
开展了一项国际性横断面观察性研究。使用Hoehn和Yahr(HY)量表以及五种残疾评定方法对患者进行评估:MDS-UPDRS第二部分、施瓦布和英格兰量表(S&E)、帕金森病严重程度临床印象指数(CISI-PD)残疾项目、巴氏指数(BI)以及残疾快速评估量表(RADS)。数据分析包括相关系数、曼-惠特尼检验和克鲁斯卡尔-沃利斯检验,以及一致性组内相关系数。
样本包括451名患者,男性占55.2%,平均年龄为65.06岁(标准差=10.71)。残疾评定量表的相关性从|0.75|(CISI-PD残疾项目与BI)到0.87(MDS-UPDRS第二部分与RADS)。总体而言,MDS-UPDRS第二部分与临床变量显示出高相关系数,与其他残疾评定方法具有令人满意的一致性,组内相关系数范围从0.83(与BI)到0.93(与RADS)。所有残疾评定量表在按性别、年龄、病程和严重程度分组的样本中均显示出统计学显著差异。
MDS-UPDRS第二部分在评估帕金森病残疾方面表现良好,甚至优于本研究中应用的一些基于评估者的通用或特异性量表。